Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
184.6 EUR | -0.91% | +1.09% | -22.90% |
Jun. 03 | SARTORIUS STEDIM BIOTECH : EPS cut (2023: -13.7%, 2024: -16.4%) | |
May. 16 | Sartorius sinks again towards year low | DP |
Sales 2024 * | 2.94B 3.17B | Sales 2025 * | 3.33B 3.59B | Capitalization | 17.97B 19.41B |
---|---|---|---|---|---|
Net income 2024 * | 335M 362M | Net income 2025 * | 451M 487M | EV / Sales 2024 * | 6.89 x |
Net Debt 2024 * | 2.27B 2.45B | Net Debt 2025 * | 2.16B 2.33B | EV / Sales 2025 * | 6.05 x |
P/E ratio 2024 * |
52
x | P/E ratio 2025 * |
37.4
x | Employees | 10,493 |
Yield 2024 * |
0.4% | Yield 2025 * |
0.59% | Free-Float | 31.97% |
Latest transcript on Sartorius Stedim Biotech
1 day | -0.91% | ||
1 week | +1.09% | ||
Current month | +1.09% | ||
1 month | -9.66% | ||
3 months | -31.59% | ||
6 months | -9.84% | ||
Current year | -22.90% |
Managers | Title | Age | Since |
---|---|---|---|
René Fáber
CEO | Chief Executive Officer | 48 | 19-03-25 |
Chairman | 59 | 07-06-28 | |
Chief Tech/Sci/R&D Officer | 59 | 09-04-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Henri Riey
BRD | Director/Board Member | 62 | 07-06-28 |
Chairman | 59 | 07-06-28 | |
Susan Dexter
BRD | Director/Board Member | 67 | 15-04-06 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.42% | 21 M€ | +8.41% | - | |
0.35% | 5 M€ | +4.56% |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 184.6 | -0.91% | 52,754 |
24-06-06 | 186.4 | +1.06% | 58,644 |
24-06-05 | 184.4 | +2.84% | 56,218 |
24-06-04 | 179.3 | -1.24% | 57,959 |
24-06-03 | 181.6 | -0.60% | 62,448 |
Real-time Euronext Paris, June 07, 2024 at 11:35 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.90% | 19.42B | |
-2.26% | 187B | |
+2.05% | 110B | |
-1.31% | 69.54B | |
+14.65% | 46.37B | |
-6.69% | 46.05B | |
+7.97% | 42.54B | |
+18.60% | 30.72B | |
+16.92% | 25.62B | |
-6.87% | 23.32B |
- Stock Market
- Equities
- DIM Stock